Ilex Medical Ltd (TLV:ILX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
6,347.00
-5.00 (-0.08%)
At close: Jan 30, 2026

Ilex Medical Balance Sheet

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
163.3177.25148.38200.96259.23159.83
Short-Term Investments
26.7725.8741.252.74--
Trading Asset Securities
54.4533.7627.482225.5215.93
Cash & Short-Term Investments
244.51236.88217.11225.7284.75175.75
Cash Growth
35.09%9.11%-3.81%-20.74%62.02%101.31%
Accounts Receivable
227.88249.37286.25248.26219.99239.46
Other Receivables
6.0217.5615.573.043.730.38
Receivables
233.89266.93301.82251.3223.72239.84
Inventory
186.2157.89159.68145.8116.32136.68
Other Current Assets
19.656.777.3912.026.936.72
Total Current Assets
684.2718.47686.01634.83631.72558.99
Property, Plant & Equipment
153.15155.46160.91145.28151.41154.78
Long-Term Investments
6753.7157.9572.6632.10.45
Goodwill
7.017.017.017.01--
Other Intangible Assets
13.6317.0821.2725.0625.8731.69
Long-Term Accounts Receivable
-34.9128.515.733.756.42
Long-Term Deferred Tax Assets
6.097.428.516.356.354.46
Long-Term Deferred Charges
---0.040.080.08
Other Long-Term Assets
38.850.0145.952.2323.822.38
Total Assets
969.92994.071,016899.18875.07779.25
Accounts Payable
129.37120.44172.11142.32124.39162.79
Accrued Expenses
-----40.2
Short-Term Debt
-----0.22
Current Portion of Long-Term Debt
-0.310.410.561.1315.27
Current Portion of Leases
12.3312.2211.4712.2811.968.56
Current Income Taxes Payable
5.494.51.42.2240.397.22
Current Unearned Revenue
-----33.4
Other Current Liabilities
91.7130.493.1568.4562.2311.58
Total Current Liabilities
238.89267.87278.54225.83240.11279.22
Long-Term Debt
--0.310.731.292.42
Long-Term Leases
36.6438.8136.0737.9944.3640.28
Long-Term Unearned Revenue
8.0125.2860.334.11-6.08
Pension & Post-Retirement Benefits
0.960.961.63---
Long-Term Deferred Tax Liabilities
2.222.552.943.156.727.58
Other Long-Term Liabilities
9.4712.1212.7714.287.020.12
Total Liabilities
296.18347.58392.61286.08299.49335.71
Common Stock
12.4812.4812.4812.4812.4812.48
Additional Paid-In Capital
150.5150.5150.5150.5150.5150.5
Retained Earnings
591.96568.58544.92515.41472.39334.63
Treasury Stock
-9.2-9.2-9.2-3.49--
Comprehensive Income & Other
-71.99-75.86-75.19-61.79-59.79-54.07
Total Common Equity
673.74646.49623.51613.1575.57443.54
Shareholders' Equity
673.74646.49623.51613.1575.57443.54
Total Liabilities & Equity
969.92994.071,016899.18875.07779.25
Total Debt
48.9651.3548.2751.5558.7466.74
Net Cash (Debt)
195.55185.53168.84174.15226.02109.01
Net Cash Growth
54.21%9.88%-3.04%-22.95%107.33%-
Net Cash Per Share
17.5016.5815.0915.4420.0410.22
Filing Date Shares Outstanding
11.2111.1911.2811.2811.2811.28
Total Common Shares Outstanding
11.2111.1911.1911.2511.2811.28
Working Capital
445.31450.6407.47409391.61279.77
Book Value Per Share
60.0957.7855.7354.5251.0239.32
Tangible Book Value
653.11622.4595.24581.04549.7411.85
Tangible Book Value Per Share
58.2555.6353.2051.6748.7336.51
Land
-0.060.060.060.060.06
Machinery
-254.19244.49212.94193.36188.2
Leasehold Improvements
-17.7825.1924.0425.5125.36
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.